financetom
Business
financetom
/
Business
/
Syntheia Signs Definitive Agreement for Call Center Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Syntheia Signs Definitive Agreement for Call Center Acquisition
Jul 7, 2025 6:34 AM

09:02 AM EDT, 07/07/2025 (MT Newswires) -- Syntheia (SYAI.CN) over the weekend said it signed a definitive agreement dated July 5, to acquire certain assets from Call Center Guys, an arm's length party.

The assets consist primarily of employees, customers and intellectual property, said Syntheia.

Syntheia will pay with 20 million of its common shares and $8 million in cash to be financed through a debt. The closing is expected following completion of the debt financing, the company said.

"This acquisition, upon completion will bring an immediate $10M+ in revenue with a projected $2.2M+ of EBITDA on annual basis," said Syntheia Chief Executive Tony Di Benedetto. "When we then combine with our Syntheia conversational AI platform, we expect savings and efficiencies resulting from deploying our technology of 30% while increasing the customer experience. Welcome to the power of AI."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PharmaTher Provides Update on FDA New Drug Application for Ketamin
PharmaTher Provides Update on FDA New Drug Application for Ketamin
Nov 26, 2024
08:43 AM EST, 11/26/2024 (MT Newswires) -- PharmaTher Holdings ( PHRRF ) on Tuesday said it will cancel its meeting with the U.S. Food and Drug Administration after the regulator responded to its questions that were in the post-complete response letter clarification meeting scheduled for Dec. 2. The responses were satisfactory and do not require further discussion, the company said....
Dr. Reddy's Laboratories Launches Anti-Parasitic Drug Ivermectin
Dr. Reddy's Laboratories Launches Anti-Parasitic Drug Ivermectin
Nov 26, 2024
08:44 AM EST, 11/26/2024 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) and Senores Pharmaceuticals said Tuesday they have launched 3 milligram Ivermectin tablets USP that are therapeutically equivalent to the Stromectol tablets made by Merck ( MRK ) Sharp and Dohme in the US market. Dr. Reddy's will market the drug, the companies said. ...
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday Ahead of FOMC Meeting Minutes
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday Ahead of FOMC Meeting Minutes
Nov 26, 2024
08:41 AM EST, 11/26/2024 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.2% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.3% in Tuesday's premarket activity, ahead of a slew of economic data followed by the Federal Open Market Committee's meeting minutes. US stock futures were mixed, with S&P...
Zoom Communications slumps as lackluster growth worries investors
Zoom Communications slumps as lackluster growth worries investors
Nov 26, 2024
By Arsheeya Bajwa Nov 26 (Reuters) - Zoom Communications shares tumbled nearly 11% before the bell on Tuesday, as its forecast for low single-digit annual revenue growth disappointed investors after a recent rally. Stiff competition from rival video conferencing services including Microsoft Teams has pressured Zoom, even as it expands its offerings with products such as phone systems and artificial...
Copyright 2023-2026 - www.financetom.com All Rights Reserved